Literature DB >> 29368019

[Unclear uveal tumor with bleeding].

R Angermann1, G Haas2, M Hofer2, M Stattin3, N E Bechrakis2, C Zehetner2.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29368019     DOI： 10.1007/s00347-018-0650-z

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN： 0941-293X            Impact factor:   1.059


× No keyword cloud information.
  5 in total

1.  Peripheral exudative hemorrhagic chorioretinopathy: polypoidal choroidal vasculopathy and hemodynamic modifications.

Authors:  Irmela Mantel; Ann Schalenbourg; Leonidas Zografos
Journal:  Am J Ophthalmol       Date:  2012-02-04       Impact factor: 5.258

2.  Clinical characteristics of peripheral exudative hemorrhagic chorioretinopathy and its response to bevacizumab therapy.

Authors:  E Y Pinarci; I Kilic; S A Bayar; S Sizmaz; I Akkoyun; G Yilmaz
Journal:  Eye (Lond)       Date:  2012-11-16       Impact factor: 3.775

3.  Pseudomelanomas of the posterior uveal tract: the 2006 Taylor R. Smith Lecture.

Authors:  Jerry A Shields; Arman Mashayekhi; Seong Ra; Carol L Shields
Journal:  Retina       Date:  2005-09       Impact factor: 4.256

4.  Anti-VEGF therapy in symptomatic peripheral exudative hemorrhagic chorioretinopathy (PEHCR) involving the macula.

Authors:  Ira Seibel; Annette Hager; Tobias Duncker; Aline I Riechardt; Daniela Nürnberg; Julian P Klein; Matus Rehak; Antonia M Joussen
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-07-07       Impact factor: 3.117

5.  Peripheral exudative hemorrhagic chorioretinopathy: a clinical, angiographic, and histologic study.

Authors:  Irmela Mantel; Sylvie Uffer; Leonidas Zografos
Journal:  Am J Ophthalmol       Date:  2009-10-02       Impact factor: 5.258
  5 in total
  1 in total

1.  [Reasons and risk factors for recurrent retinal detachment after removal of silicon oil in various vitreoretinal diseases].

Authors:  Agharza Ashurov; Melanie Hundhammer; Walter Sekundo; Stephan Schulze
Journal:  Ophthalmologe       Date:  2021-06-04       Impact factor: 1.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.